| Ytd | -42.97% | |
| 1y | -80.55% |
| Open | 0.44 | Prev Close | 0.43 | Low | 0.42 | High | 0.44 | Mkt Cap | 9.10M |
| Vol | 434.06K | Avg Vol | 12.84M | EPS | -1.02 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.98 | Short Ratio | 0.21 | Inst. Own | 4.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.44 | 200-d Avg | 0.45 | 1yr Est | 0.00 |
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support
Transaction follows a $2. 5 million strategic investment commitment at MangoRx IP Holdings to suppor
U.S. stock futures advanced on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, fo
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Frida
U.S. stock futures rose, while Nike plunged 9.5% after missing revenue estimates. Roze AI, Mangoceut
Nike falls on weak revenue; Synaptics jumps on $123 ON deal; AsiaStrategy surges on tokenization pac
Mangoceuticals shares fall 12% after hours despite a $2.5 million strategic investment in its antivi
Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company’s Antiviral
Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company's Antiviral
Chemed (NYSE: CHE - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both he
LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free
Planet Green Holdings Corp (NYSE: PLAG) saw a sharp increase in pre-market trading after Curvature S
On August 19, 2026, Mangoceuticals, Inc. (the "Company" or "MGRX") and Nuclea Energy
Gainers IP Strategy Holdings (NASDAQ:IPST) shares rose 13.2% to $8.37 during Monday's after-mar
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
Gainers Mangoceuticals (NASDAQ:MGRX) shares increased by 40.0% to $0.75 during Thursday's after
The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96
The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 mil
The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 mil
MoU with New Mining Co. ("New Mining"), a Miami-headquartered provider of high-density digit
The MOU will assess the technical feasibility of integrating Nuclea's modular reactor technology int
MOU will assess the technical feasibility of integrating Nuclea's modular reactor technology into Ne
SiTime Corp (SITM) stock rose 30.7% in pre-market trading after beating earnings and sales estimates
Mangoceuticals Shares surged 49.24% after hours as Nuclea Energy advanced nuclear reactor plans boos
Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") today announ
The MOU supports exploration of a nuclear test reactor site at the Utah San Rafael Energy Lab to adv
The MOU supports exploration of a nuclear test reactor site at the Utah San Rafael Energy Lab and en
Dallas, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceutical
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market ses
Atkore Inc (ATKR) shares rise on strong Q3 results and acquisition by Prysmian for $95.00 per share.
US stocks rise, Nasdaq up 300 points. Dow up 0.36%, Nasdaq up 1.31%, S&P 500 up 0.65%. Amazon sh
Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pr
Mangoceuticals shares jumped 137.77% after hours following its definitive business combination agree
Transaction positions Nuclea to fund the development and commercialization of its lead-cooled, facto
Business Combination Agreement to Bring Nuclea's Lead-Cooled Morpheus Microreactor to the Public Mar
Gainers Sadot Group (NASDAQ:SDOT) stock rose 22.1% to $61.7 during Monday's pre-market session.
Mangoceuticals (NASDAQ: MGRX - Get Free Report) and Lipocine (NASDAQ: LPCN - Get Free Report) are bo
Mangoceuticals (NASDAQ: MGRX - Get Free Report) and Lyell Immunopharma (NASDAQ: LYEL - Get Free Repo
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.13) per share. This is a 87.13 percent
Mangoceuticals Inc. (NASDAQ: MGRX) shares are surging on Monday. However, there is no news to justif
Mangoceuticals stock jumps despite no fresh news, as lawsuit dispute, TRT sales surge, and platform
Dow Jones rises over 800 points on Monday as U.S. stocks trade higher. NASDAQ and S&P 500 also s
Faraday Future Intelligent Electric shares up 54.8% in pre-market trading after SEC investigation en
Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceutica
Mangoceuticals, Inc. (NASDAQ:MGRX), a company focused on developing, marketing, and selling a variet
Mangoceuticals, Inc. (NASDAQ:MGRX), a company focused on developing, marketing, and selling a variet
Shares of Mangoceuticals are trading sharply higher Friday afternoon after the company reported mome